Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of a Sirolimus Eluting Bioadaptor as Compared to a Zotarolimus Eluting Stent in De Novo Native Coronary Arteries ELX-CL-1805

NCT04192747 is registered in ClinicalTrials.gov with Elixir Medical Corporation as lead sponsor.

NCT NCT04192747
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04192747 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of a Sirolimus Eluting Bioadaptor as Compared to a Zotarolimus Eluting Stent in De Novo Native Coronary Arteries ELX-CL-1805
Lead sponsor
Elixir Medical Corporation
Phase
Not applicable
Overall status
Active, not recruiting
Start date
December 16, 2020
Completion date
February 28, 2027
Enrollment
445 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, coronary artery stenosis, coronary disease, coronary stenosis